Themis Karmiris
Athens, ESYE31, Greece
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Real-life Experience With Rituximab-CHOP Every 21 or 14 Days in Primary Mediastinal Large B-cell Lymphoma.
Journal: In vivo (Athens, Greece)
Published: March 01, 2022
Subdiaphragmatic extranodal localizations at diagnosis of primary mediastinal large B-cell lymphoma: an impressive, rare presentation with no independent effect on prognosis.
Journal: Leukemia research
Published: February 09, 2021
Positron emission tomography after response to rituximab-CHOP in primary mediastinal large B-cell lymphoma: impact on outcomes and radiotherapy strategies.
Journal: Annals of hematology
Published: November 17, 2020
Comparison of Risk Factor Profiles for Primary Open-Angle Glaucoma Subtypes Defined by Pattern of Visual Field Loss: True Risk Factors or Arbitrary Definition?
Journal: Investigative ophthalmology & visual science
Published: October 10, 2015
Clinical trial evaluating Viscoat and Visthesia ophthalmic viscosurgical devices in corneal endothelial loss after cataract extraction and intraocular lens implantation.
Journal: Cutaneous and ocular toxicology
Published: October 26, 2013
Primary bone lymphoma: a retrospective analysis of 22 patients treated in a single tertiary center.
Journal: Acta haematologica
Published: January 14, 2013
Showing 1-9 of 9
Last Updated: 09/26/2026